Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB175404

IL-27 p28/IL-30 Antibody (234205), DyLight 488, Novus Biologicals™
SDP

Catalog No. NB175404 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.5 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB175404 0.5 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. NB175404 Supplier Novus Biologicals Supplier No. FAB1834K
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Rat Monoclonal Antibody

IL-27 p28/IL-30 Monoclonal antibody specifically detects IL-27 p28/IL-30 in Mouse samples. It is validated for Western Blot, Flow Cytometry

Specifications

Antigen IL-27 p28/IL-30
Applications Western Blot, Flow Cytometry
Classification Monoclonal
Clone 234205
Conjugate DyLight 488
Formulation 50mM Sodium Borate
Host Species Rat
Immunogen Chinese hamster ovary cell line CHO-derived recombinant mouse IL-27, Tyr19-Pro228 (EBI3) & Phe29-Ser234 (p28), Accession # O35228 (EBI3) & Q8K3I6 (p28)
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.5 mL
Regulatory Status RUO
Primary or Secondary Primary
Target Species Mouse
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.